packagePegloticase

pegloticase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Pegloticase is an enzyme-based medicine used to treat gout. It is approved and used for chronic gout that does not respond to standard therapy, mainly in the United States; a product was withdrawn in the European Union.

Summary written by glm-5.3-flash from Wikidata Q7160794 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:pegloticase
ATC codes:M04AX02
DrugBank:DB09208
Wikidata:Q7160794
molar mass:34192.9 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown